Rising to the Challenge of Unmet Needs in ACS, SSP, and AF Through Next-Generation Anticoagulation Strategies

This is a separately accredited session.

Jeffrey Weitz, MD, FRCPC, FRSC, FACP

Professor of Medicine & Biochemistry, McMaster University

Heart & Stroke Foundation/J.F. Mustard Chair in Cardiovascular Research, Canada Research Chair (Tier 1) in Thrombosis

Executive Director, Thrombosis & Atherosclerosis Research Institute

Hamilton, Ontario, Canada

Let’s Beat HCM!

This is a separately accredited session. 

In conjunction with Association of Black Cardiologists

Adedapo Iluyomade, MD, FACC
Baptist Health

This initiative focuses on improving the screening, diagnosis, and management of hypertrophic cardiomyopathy (HCM)—a genetic condition that can obstruct blood flow and lead to serious complications, including sudden cardiac death.

BAXFENDY in Everyday Practice: A New Era of Hypertension Management

This is a separately accredited session.

Patrick Cambier, MD, FACC
Interventional Cardiac Consultants

Taking Initiative to Optimize Lipid-Lowering Therapy in High-Risk Patients With ASCVD: A Call to Action for Cardiologists

This is a separately accredited session.

Heather Johnson, MD, MS, MMM, FAHA, FACC, FASPC

Baptist Health